Abstract
Ketosis prone type 2 diabetes (KPD) is presently a well-defined clinical entity, characterized by a debut with severe hyperglycemia and ketoacidosis similar to the presenting form of Type 1 diabetes mellitus (DM1). However, it appears in subjects with Type 2 diabetes mellitus (DM2) phenotype. This situation is caused by an acute, reversible dysfunction of the beta cell in individuals with insulin resistance. Once the acute stage subsides, patients behave as having a DM2 and do not require insulin treatment. They should be kept on a diet and oral hypoglycemic drugs due to their susceptibility to have recurrent acute ketotic decompensations.
Highlights
Ketosis prone type 2 diabetes (KPD) is presently a well-defined clinical entity, characterized by a debut with severe hyperglycemia and ketoacidosis similar to the presenting form of Type 1 diabetes mellitus (DM1)
Se ha informado que los pacientes con DTC tienen altos niveles basales de glucagón y la supresión de su liberación esta disminuida[19], lo que sugiere que las células alfa podrían ser importantes en la patogenia de este subtipo de diabetes
Ha sido descrita en varios países incluido Chile
Summary
Ketosis prone type 2 diabetes (KPD) is presently a well-defined clinical entity, characterized by a debut with severe hyperglycemia and ketoacidosis similar to the presenting form of Type 1 diabetes mellitus (DM1). It appears in subjects with Type 2 diabetes mellitus (DM2) phenotype. Once the acute stage subsides, patients behave as having a DM2 and do not require insulin treatment. They should be kept on a diet and oral hypoglycemic drugs due to their susceptibility to have recurrent acute ketotic decompensations. Este “subtipo” de DM se ha denominado diabetes mellitus tipo 2 con tendencia a la cetosis (DTC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have